WCM Investment Management CA boosted its position in Cooper Companies Inc (NYSE:COO) by 2.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 393,780 shares of the medical device company’s stock after acquiring an additional 9,921 shares during the quarter. Cooper Companies accounts for about 0.8% of WCM Investment Management CA’s holdings, making the stock its 13th biggest holding. WCM Investment Management CA owned 0.80% of Cooper Companies worth $90,101,000 at the end of the most recent reporting period.
A number of other large investors have also recently modified their holdings of the stock. BlackRock Inc. raised its holdings in Cooper Companies by 0.9% in the first quarter. BlackRock Inc. now owns 3,647,931 shares of the medical device company’s stock valued at $834,681,000 after acquiring an additional 31,592 shares in the last quarter. Massachusetts Financial Services Co. MA raised its holdings in Cooper Companies by 4.6% in the first quarter. Massachusetts Financial Services Co. MA now owns 2,730,859 shares of the medical device company’s stock valued at $624,849,000 after acquiring an additional 119,970 shares in the last quarter. Amundi Pioneer Asset Management Inc. raised its holdings in Cooper Companies by 10.1% in the fourth quarter. Amundi Pioneer Asset Management Inc. now owns 1,379,094 shares of the medical device company’s stock valued at $300,476,000 after acquiring an additional 126,156 shares in the last quarter. Frontier Capital Management Co. LLC raised its holdings in Cooper Companies by 6.6% in the first quarter. Frontier Capital Management Co. LLC now owns 699,460 shares of the medical device company’s stock valued at $160,043,000 after acquiring an additional 43,009 shares in the last quarter. Finally, Geode Capital Management LLC raised its holdings in Cooper Companies by 3.2% in the fourth quarter. Geode Capital Management LLC now owns 583,128 shares of the medical device company’s stock valued at $126,817,000 after acquiring an additional 17,942 shares in the last quarter. 94.97% of the stock is currently owned by hedge funds and other institutional investors.
Several analysts recently weighed in on COO shares. Stephens reaffirmed a “hold” rating and issued a $270.00 target price on shares of Cooper Companies in a report on Friday, March 9th. Oppenheimer set a $265.00 target price on shares of Cooper Companies and gave the company a “hold” rating in a report on Thursday, March 29th. Zacks Investment Research cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Monday. Jefferies Group reaffirmed a “buy” rating and issued a $285.00 target price on shares of Cooper Companies in a report on Friday, March 9th. Finally, Goldman Sachs Group started coverage on shares of Cooper Companies in a report on Wednesday, April 4th. They issued a “neutral” rating and a $231.00 target price on the stock. Eight equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $264.91.
COO stock traded up $0.32 during midday trading on Thursday, reaching $232.24. 3,912 shares of the company were exchanged, compared to its average volume of 308,454. The company has a current ratio of 2.83, a quick ratio of 1.61 and a debt-to-equity ratio of 0.75. Cooper Companies Inc has a 1-year low of $215.24 and a 1-year high of $260.26. The stock has a market cap of $11.37 billion, a P/E ratio of 23.91, a PEG ratio of 1.83 and a beta of 0.62.
Cooper Companies (NYSE:COO) last released its quarterly earnings data on Thursday, March 8th. The medical device company reported $2.79 earnings per share for the quarter, topping analysts’ consensus estimates of $2.51 by $0.28. Cooper Companies had a net margin of 7.83% and a return on equity of 16.90%. The company had revenue of $590.00 million for the quarter, compared to analysts’ expectations of $583.07 million. During the same quarter last year, the company earned $1.93 earnings per share. The firm’s revenue for the quarter was up 18.2% on a year-over-year basis. equities research analysts predict that Cooper Companies Inc will post 11.82 earnings per share for the current year.
Cooper Companies Profile
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.